Phase I Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive Non-Small Cell Lung Cancer (JVDF)

被引:1
|
作者
Herbst, R. [1 ]
Arkenau, H. [2 ]
Bendell, J. [3 ]
Arrowsmith, E. [4 ]
Wermke, M. [5 ]
Soriano, A. [6 ]
Penel, N. [7 ]
Santana-Davila, R. [8 ]
Bischoff, H. [9 ]
Chau, I. [10 ]
Chao, B. [11 ]
Ferry, D. [11 ]
Mi, G. [12 ]
Paz-Ares, L. [13 ]
机构
[1] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA
[2] UCL, Sarah Cannon Res Inst, London, England
[3] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[4] Tennessee Oncol, Nashville, TN USA
[5] Univ Hosp Carl Gustav Carus, Dresden, Germany
[6] Florida Canc Specialists, Englewood, FL USA
[7] Ctr Oscar Lambret, Lille, France
[8] Univ Washington, Seattle, WA 98195 USA
[9] Thoraxklin Heidelberg Ggmbh, Heidelberg, Germany
[10] Royal Marsden Hosp, Sutton, Surrey, England
[11] Eli Lilly & Co, New York, NY USA
[12] Eli Lilly & Co, Indianapolis, IN 46285 USA
[13] 12 Octubre Univ Hosp, Seville, Spain
关键词
Ramucirumab; Pembrolizumab; Lung cancer;
D O I
10.1016/j.jtho.2019.08.615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA14.07
引用
收藏
页码:S307 / S307
页数:1
相关论文
共 50 条
  • [1] Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC
    Herbst, Roy S.
    Arkenau, Hendrik Tobias
    Bendell, Johanna
    Arrowsmith, Edward
    Wermke, Martin
    Soriano, Andres
    Penel, Nicolas
    Santana-Davila, Rafael
    Bischoff, Helge
    Chau, Ian
    Mi, Gu
    Wang, Hong
    Rasmussen, Erik
    Ferry, David
    Chao, Bo H.
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 289 - 298
  • [2] A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer
    Huang, Chun-Yao
    Huang, Hui-Li
    Lan, Chou-Chin
    Huang, Yi-Chih
    Wu, Yao-Kuang
    BMC CANCER, 2023, 23 (01)
  • [3] Advanced non-small cell lung cancer - treatment with Pembrolizumab
    Silvinato, Antonio
    Floriano, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 256 - 256
  • [4] Advanced non-small cell lung cancer - Treatment with Pembrolizumab
    Silvinato, Antonio
    Floriono, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1423 - 1432
  • [5] Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer
    Gray, Jhanelle E.
    Saltos, Andreas
    Tanvetyanon, Tawee
    Haura, Eric B.
    Creelan, Ben
    Antonia, Scott J.
    Shafique, Michael
    Zheng, Hong
    Dai, Wenjie
    Saller, James J.
    Chen, Zhihua
    Tchekmedyian, Nishan
    Goas, Kristen
    Thapa, Ram
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Beg, Amer A.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6623 - 6632
  • [6] Safety and antitumor activity from the phase lb study of ramucirumab plus pembrolizumab in treatment-naive advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (JVDF)
    Chau, I.
    Bendell, J.
    Soriano, A.
    Arkenau, H.
    Cultreras, J.
    Santana-Davila, R.
    Calvo, E.
    Le Toumeau, C.
    Zender, L.
    Mi, G.
    Schelman, W.
    Ferry, D.
    Herbst, R.
    Fuchs, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 122 - 122
  • [7] Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer
    Takeda, Koji
    Daga, Haruko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1541 - 1547
  • [8] Effectiveness of Ramucirumab Plus Docetaxel for Advanced Non-Small Cell Lung Cancer Patients: a Cohort of 93 Patients
    Barcelos, Isabella Favato
    De Marchi, Pedro
    Aguiar Junior, Pedro Nazareth
    Montella, Tatiane Caldas
    Afonso, Nathalia Gimenes
    Visani, Filipe
    Negreiros, Izabella Santos
    De Cerqueira Mathias, Clarissa Maria
    Paes, Rafael Duarte
    Dienstmann, Rodrigo
    Ferreira, Carlos Gil
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S13 - S13
  • [9] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [10] Ramucirumab in Combination with Pembrolizumab in Treatment-Naive Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
    Chau, Ian
    Penel, Nicolas
    Soriano, Andres O.
    Arkenau, Hendrik-Tobias
    Cultrera, Jennifer
    Santana-Davila, Rafael
    Calvo, Emiliano
    Le Tourneau, Christophe
    Zender, Lars
    Bendell, Johanna C.
    Mi, Gu
    Gao, Ling
    McNeely, Samuel Clark
    Oliveira, Joana M.
    Ferry, David
    Herbst, Roy S.
    Fuchs, Charles S.
    CANCERS, 2020, 12 (10) : 1 - 16